209 related articles for article (PubMed ID: 19832807)
81. Short communication: spectrum of non-Hodgkin lymphoma in an urban Ryan White-funded clinic in the established antiretroviral era.
Silverton A; Gunthel C; Adamski M; Mosunjac M; Nguyen ML
AIDS Res Hum Retroviruses; 2014 Jul; 30(7):665-9. PubMed ID: 24707838
[TBL] [Abstract][Full Text] [Related]
82. Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma.
Palanisamy N; Abou-Elella AA; Chaganti SR; Houldsworth J; Offit K; Louie DC; Terayu-Feldstein J; Cigudosa JC; Rao PH; Sanger WG; Weisenburger DD; Chaganti RS
Genes Chromosomes Cancer; 2002 Feb; 33(2):114-22. PubMed ID: 11793437
[TBL] [Abstract][Full Text] [Related]
83. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
[TBL] [Abstract][Full Text] [Related]
84. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.
Bellan C; Lazzi S; Hummel M; Palummo N; de Santi M; Amato T; Nyagol J; Sabattini E; Lazure T; Pileri SA; Raphael M; Stein H; Tosi P; Leoncini L
Blood; 2005 Aug; 106(3):1031-6. PubMed ID: 15840698
[TBL] [Abstract][Full Text] [Related]
85. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
[TBL] [Abstract][Full Text] [Related]
86. Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors, I.
Delecluse HJ; Raphael M; Magaud JP; Felman P; Alsamad IA; Bornkamm GW; Lenoir GM
Blood; 1993 Jul; 82(2):552-63. PubMed ID: 8392399
[TBL] [Abstract][Full Text] [Related]
87. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
[TBL] [Abstract][Full Text] [Related]
88. Identification of candidate B-lymphoma genes by cross-species gene expression profiling.
Tompkins VS; Han SS; Olivier A; Syrbu S; Bair T; Button A; Jacobus L; Wang Z; Lifton S; Raychaudhuri P; Morse HC; Weiner G; Link B; Smith BJ; Janz S
PLoS One; 2013; 8(10):e76889. PubMed ID: 24130802
[TBL] [Abstract][Full Text] [Related]
89. Analysis of the coding genome of diffuse large B-cell lymphoma.
Pasqualucci L; Trifonov V; Fabbri G; Ma J; Rossi D; Chiarenza A; Wells VA; Grunn A; Messina M; Elliot O; Chan J; Bhagat G; Chadburn A; Gaidano G; Mullighan CG; Rabadan R; Dalla-Favera R
Nat Genet; 2011 Jul; 43(9):830-7. PubMed ID: 21804550
[TBL] [Abstract][Full Text] [Related]
90. Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Ma MCJ; Tadros S; Bouska A; Heavican T; Yang H; Deng Q; Moore D; Akhter A; Hartert K; Jain N; Showell J; Ghosh S; Street L; Davidson M; Carey C; Tobin J; Perumal D; Vose JM; Lunning MA; Sohani AR; Chen BJ; Buckley S; Nastoupil LJ; Davis RE; Westin JR; Fowler NH; Parekh S; Gandhi M; Neelapu S; Stewart D; Bhalla K; Iqbal J; Greiner T; Rodig SJ; Mansoor A; Green MR
Haematologica; 2022 Mar; 107(3):690-701. PubMed ID: 33792219
[TBL] [Abstract][Full Text] [Related]
91. An Indian Perspective on HIV-associated Lymphomas.
Barta SK
N Am J Med Sci; 2013 Jul; 5(7):438-9. PubMed ID: 24020056
[No Abstract] [Full Text] [Related]
92. Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.
Ok CY; Li L; Xu-Monette ZY; Visco C; Tzankov A; Manyam GC; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Chen J; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ai W; Ponzoni M; Ferreri AJ; Farnen JP; Møller MB; Bueso-Ramos CE; Miranda RN; Winter JN; Piris MA; Medeiros LJ; Young KH
Clin Cancer Res; 2014 May; 20(9):2338-49. PubMed ID: 24583797
[TBL] [Abstract][Full Text] [Related]
93. Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system.
de Portu S; Del Giglio M; Altomare G; Arcangeli F; Berardesca E; Calzavara-Pinton P; Lotti T; Martini P; Peserico A; Simonacci M; Vena GA; Girolomoni G
Dermatol Ther; 2010; 23 Suppl 1():S7-13. PubMed ID: 20136921
[TBL] [Abstract][Full Text] [Related]
94. Genome-wide DNA profiling of HIV-related B-cell lymphomas.
Rinaldi A; Capello D; Zucca E; Gaidano G; Bertoni F
Methods Mol Biol; 2013; 973():213-26. PubMed ID: 23412793
[TBL] [Abstract][Full Text] [Related]
95. Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature.
Maguire A; Chen X; Wisner L; Malasi S; Ramsower C; Kendrick S; Barrett MT; Glinsmann-Gibson B; McGrath M; Rimsza LM
Int J Cancer; 2019 Dec; 145(11):3078-3088. PubMed ID: 31044434
[TBL] [Abstract][Full Text] [Related]
96. Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.
Besson C; Lancar R; Prevot S; Algarte-Genin M; Delobel P; Bonnet F; Meyohas MC; Partisani M; Oberic L; Gabarre J; Goujard C; Boue F; Coppo P; Costello R; Hendel-Chavez H; Mekerri N; Dos Santos G; Recher C; Delarue R; Casasnovas RO; Taoufik Y; Mounier N; Costagliola D;
AIDS; 2017 Nov; 31(18):2493-2501. PubMed ID: 28926410
[TBL] [Abstract][Full Text] [Related]
97. Still Far to Go With Characterisation of Molecular and Genetic Features of Diffuse Large B-Cell Lymphoma in People Living With HIV: A Scoping Review.
Manyau MCP; Zambuko B; Chatambudza M; Zhou DT; Manasa J
Oncol Rev; 2024; 18():1375291. PubMed ID: 38707485
[TBL] [Abstract][Full Text] [Related]
98. Carcinogenic mechanisms of virus-associated lymphoma.
Zhang Y; Guo W; Zhan Z; Bai O
Front Immunol; 2024; 15():1361009. PubMed ID: 38482011
[TBL] [Abstract][Full Text] [Related]
99. MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.
Pagani C; Rusconi C; Dalla Pria A; Ravano E; Schommers P; Bastos-Oreiro M; Verga L; Gini G; Spina M; Arcaini L; Steffanoni S; Dalu D; Crucitti L; Lorenzi L; Balzarini P; Cattaneo C; Bongiovanni L; Rosenwald A; Facchetti F; Bower M; Ferreri AJM; Rossi G; Tucci A; Re A
Blood Adv; 2024 Feb; 8(4):968-977. PubMed ID: 38207206
[TBL] [Abstract][Full Text] [Related]
100. Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma.
Lin SH; Khan SM; Zhou W; Brown DW; Vergara C; Wolinsky SM; Martínez-Maza O; Margolick JB; Martinson JJ; Hussain SK; Engels EA; Machiela MJ
AIDS; 2023 Jul; 37(8):1307-1313. PubMed ID: 36927626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
